Joel Morely, the U.S. spokesman for NicOx S.A., the French biotechnology company that funded the story, says it hopes to have a safety study of the drug in people going by the middle of this year. The company also is looking at using the drug to treat colon cancer, Morely says. Or, you might want to read previous HealthScout articles on angioplasty and on heart disease . Get Your Medifocus Medguide Research Your Illness Visit our Medcenter and get your Medifocus Guide , trustworthy medical information specifically about your health condition. Bookstore Stop by our bookstore and catch up on the latest treatments and remedies for your illness.
Current members login here .
Get our best features delivered directly to you. All rights reserved.